Table 3.
Association between DRN (autoreceptor) and heteroreceptor 5-HT1A BPND representing correlation coefficients R and regression slopes β for each group separately
| Region | Anatomical ROI |
Functional ROI |
|||
|---|---|---|---|---|---|
| Healthy controls | Patients |
Patients |
|||
| Before SSRI | After SSRI | Before SSRI | After SSRI | ||
| Correlation coefficient R | |||||
| Amygdala | |||||
| Right | 0.56*** | 0.5* | 0.79*** | 0.46* | 0.88*** |
| Left | 0.55*** | 0.51* | 0.73** | 0.49* | 0.9*** |
| Hippocampus | |||||
| Right | 0.45** | 0.53* | 0.73** | 0.47* | 0.82*** |
| Left | 0.47** | 0.49* | 0.7** | 0.5* | 0.85*** |
| Regression slope β | |||||
| Amygdala | |||||
| Right | 0.99*** | 0.87* | 1.91*** | 0.8* | 2.74*** |
| Left | 1.07*** | 0.9* | 1.5** | 1* | 2.61*** |
| Hippocampus | |||||
| Right | 0.86** | 1.04* | 2** | 0.78* | 2.5*** |
| Left | 0.97** | 1.23* | 1.92** | 1* | 2.7*** |
ROIs were defined (1) anatomically (Stein et al., 2008) [ROI atlas-based (Tzourio-Mazoyer et al., 2002)] and (2) functionally comprising clusters with significant differences between patients before and after treatment** (see Fig. 2a,b).
*p < 0.05; **p < 0.01; ***p < 0.001, all parameters survive correction for multiple comparisons (p < 0.05, FDR).